Ketamine ointment as a transdermal antidepressant

Tuesday, July 25, 2023
We developed a novel, shea butter-based ketamine ointment, and showed that transdermal ketamine ameliorated behavioral despair without altering general locomotor activity and anxiety-like behavior. Combining behavioral assessment with pharmacokinetic analysis, we suggest that skin-friendly drug carriers like shea butter may constitute promising alternatives to current routes of delivery for ketamine.
Check the free access link until 13 September: https://authors.elsevier.com/a/1hTtDbrwfIqVn